RecallGuide.ca
    Health productsUpdated Jan 3, 2026MintOfficial source

    Mint-Losartan recall in Canada: contamination risk

    Share:

    In plain language

    This recall involves Mint-Losartan and Mint-Losartan/HCTZ tablets sold in Canada. They are being recalled because they contain an impurity above acceptable limits. Consult your healthcare provider before stopping use and follow the instructions in the official notice.

    What to do

    • Consult your healthcare provider before discontinuing use.
    • Verify if your product is affected by checking the lot number.
    • Contact the recalling firm if you have questions.
    • Report any health product related side effects to Health Canada.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Mint-Losartan/HCTZ 50mg/12.5mg

      Model: DIN 02389657

      Lot: 2005006959, 2005006960, 2005006961, 2005006962, 2005006963, 2005011154, 2005011156

    • Mint-Losartan/HCTZ 100mg/12.5mg

      Model: DIN 02389665

      Lot: 2005006807, 2005006808, 2005006809, 2005006810, 2105002149

    • Mint-Losartan/HCTZ 100mg/25mg

      Model: DIN 02389673

      Lot: 1805012687, 1805012688, 1805012689, 1805012792, 1905001010, 1905001011, 2005006947, 2005006949, 2005006950, 2005006951, 2005007297, 2005007298, 2005013776, 2105002150

    Why this matters

    Contamination risk

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: 1805012687, 1805012688, 1805012689, 1805012792, 1905001010, 1905001011, 2005006947, 2005006949, 2005006950, 2005006951, 2005007297, 2005007298, 2005013776, 2105002150, 2005006807, 2005006808, 2005006809, 2005006810, 2105002149, 2005006959, 2005006960, 2005006961, 2005006962, 2005006963, 2005011154, 2005011156

    3. 3

      Check the model number

      Model numbers are typically on the product label or packaging.

      Affected models: DIN 02389657, DIN 02389665, DIN 02389673

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Contamination risk

    What should consumers do?

    Consult your healthcare provider before discontinuing use. Verify if your product is affected by checking the lot number. Contact the recalling firm if you have questions. Report any health product related side effects to Health Canada.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Contamination risk

    When was this product recalled?

    This product was recalled on October 25, 2021.

    Is the Mint brand affected by this recall?

    Yes, Mint products are affected by this recall. This recall involves Mint-Losartan and Mint-Losartan/HCTZ tablets sold in Canada. They are being recalled because they contain an impurity above acceptable limits. Consult your healthcare provider before stopping use and follow the instructions in the official notice.